E. Bakbak

发表

Isolation and characterization of circulating pro-vascular progenitor cell subsets from human whole blood samples

S. Verma, H. Teoh, D. Hess, 2021, STAR protocols.

Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?

M. Al-Omran, S. Verma, O. Rotstein, 2021, Reviews in Endocrine and Metabolic Disorders.

Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

Deepak L. Bhatt, Lawrence A Leiter, M. Lafreniere-Roula, 2022, Circulation.

Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease.

Lawrence A Leiter, A. Demchuk, J. Tardif, 2023, Med.

Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trial

C. Mazer, H. Teoh, A. Quan, 2023, BMC Cardiovascular Disorders.

Vascular regenerative cells in cardiometabolic disease.

E. Bakbak, A. Krishnaraj, Subodh Verma, 2023, Current opinion in cardiology.

Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity.

H. Teoh, E. Bakbak, P. Puar, 2023, Cardiovascular research.

Vascular repair and regeneration in cardiometabolic diseases.

E. Bakbak, P. Puar, D. Terenzi, 2021, European heart journal.

GLP-1 receptor agonists and vascular protection.

H. Teoh, A. Quan, J. Butler, 2024, American journal of physiology. Heart and circulatory physiology.

Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial.

C. Mazer, H. Teoh, A. Quan, 2024, Med.

Vascular Regenerative Cell Deficiencies in South Asian Adults.

C. Mazer, H. Teoh, A. Quan, 2024, Journal of the American College of Cardiology.